News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Industry News TCT 2016 Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke November 01, 2016